Insights from an academic endeavor into central nervous system drug discovery.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wolters Kluwer Health, Medknow Country of Publication: India NLM ID: 101316351 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1673-5374 (Print) Linking ISSN: 16735374 NLM ISO Abbreviation: Neural Regen Res Subsets: PubMed not MEDLINE
    • Publication Information:
      Publication: 2013 - : Mumbai : Wolters Kluwer Health, Medknow
      Original Publication: Shenyang : Editorial Board of Neural Regeneration Research
    • References:
      Bjørn-Yoshimoto WE, Underhill SM (2016) The importance of the excitatory amino acid transporter 3 (EAAT3). Neurochem Int 98:4–18.
      Hauser SL, Cree BAC (2020) Treatment of multiple sclerosis: a review. Am J Med 133:1380–1390.
      Mazzucato M (2013) The entrepeneurial state. Harlow, England: Anthem Press.
      Munari F, Toschi L (2021) The impact of public funding on science valorisation: an analysis of the ERC Proof-of-Concept Programme. Res Policy 50:104211.
      Saqib U, Demaree IS, Obukhov AG, Baig MS, Ariel A, Hajela K (2024) The fate of drug discovery in academia; dumping in the publication landfill? Oncotarget 15:31–34.
      Schepers M, et al. (2023) Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis. Brain Behav Immun 109:1–22.
      Schreiber R, Govers M, van der Lugt A (2021) Innovator, entrepreneur, leader: the tripartite drug discovery neuroscientist. In: Modern CNS drug discovery (Schreiber R, eds), pp 3–22. Springer, Cham.
      Shamas-Din A, Schimmer AD (2015) Drug discovery in academia. Exp Hematol 43:713–717.
      Shimamoto K, Sakai R, Takaoka K, Yumoto N, Nakajima T, Amara SG, Shigeri Y (2004) Characterization of novel L-threo-β-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol Pharmacol 65:1008–1015.
      Thong R (2015) Root causes of the pharmaceutical R&D productivity crisis. Scitech Strateg. Available at: https://scitechstrategy.com/2015/03/31/root-causes-of-the-pharmaceutical-rd-productivity-crisis/. Accessed May 16, 2024.
      Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, Dempster E, Verfaillie C, Wasner K, Grünewald A, Prickaerts J, Pishva E, Hellings N, van den Hove D, Vanmierlo T (2023) From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta Neuropathol 146:283–299.
      Verkman AS (2004) Drug discovery in academia. Am J Physiol Physiol 286:C465–738.
    • Publication Date:
      Date Created: 20240806 Latest Revision: 20240808
    • Publication Date:
      20240808
    • Accession Number:
      10.4103/NRR.NRR-D-24-00340
    • Accession Number:
      39104109